The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma

被引：33
作者：
Davidson, B. [1 ,2 ]
机构：
[1] Oslo Univ Hosp, Dept Pathol, Norwegian Radium Hosp, Div Pathol, N-0310 Oslo, Norway
[2] Univ Oslo, Fac Med, Oslo, Norway
来源：
CYTOPATHOLOGY | 2011年 / 22卷 / 01期
关键词：
cytology; malignant mesothelioma; serous carcinoma; effusion; diagnosis; cancer biology; COMPARATIVE GENOMIC HYBRIDIZATION; EPITHELIAL OVARIAN-CANCER; FOLATE RECEPTOR-ALPHA; PLEURAL MESOTHELIOMA; PERITONEAL MESOTHELIOMA; DIFFERENTIAL-DIAGNOSIS; MONOCLONAL-ANTIBODY; GROWTH-FACTOR; LAMININ RECEPTOR; POOR SURVIVAL;
D O I：
10.1111/j.1365-2303.2010.00829.x
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma Malignant mesothelioma and ovarian/peritoneal serous carcinoma are two of the most common tumours affecting the serosal cavities. Unlike other malignant tumours diagnosed at this anatomical site, such as lung and breast carcinoma, malignant mesothelioma and serous carcinoma share a common histogenesis, may be difficult to differentiate morphologically, and co-express many of the diagnostic markers used by cytopathologists in effusion diagnosis. Selected markers have nevertheless shown sufficient sensitivity and specificity to differentiate serous carcinoma from malignant mesothelioma effectively. Recently, our group applied high throughput technology to the identification of new markers that may aid in differentiating these two cancer types and validated several of these markers in follow-up studies. This review will present current data regarding the diagnostic and biological aspects of malignant mesothelioma and ovarian/peritoneal serous carcinoma.
引用
收藏
页码：5 / 21
页数：17
相关论文
共 157 条
[91]  
MIETTINEN M, 1995, APPL IMMUNOHISTOCHEM, V3, P115
[92]   Alternative splicing generates a family of putative secreted and membrane-associated MUC4 mucins [J].
Moniaux, N ;
Escande, F ;
Batra, SK ;
Porchet, N ;
Laine, A ;
Aubert, JP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (14) :4536-4544
[93]   Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin [J].
Moniaux, N ;
Nollet, S ;
Porchet, N ;
Degand, P ;
Laine, A ;
Aubert, JP .
BIOCHEMICAL JOURNAL, 1999, 338 :325-333
[94]   Claudin proteins in human cancer: Promising new targets for diagnosis and therapy [J].
Morin, PJ .
CANCER RESEARCH, 2005, 65 (21) :9603-9606
[95]   Immunocytochemistry and DNA-image cytometry in diagnostic effusion cytology I.: Prevalence of markers in tumour cell positive and negative smears [J].
Motherby, H ;
Kube, M ;
Friedrichs, N ;
Nadjari, B ;
Knops, K ;
Donner, A ;
Baschiera, B ;
Dalquen, P ;
Böcking, A .
ANALYTICAL CELLULAR PATHOLOGY, 1999, 19 (01) :7-20
[96]   The potential value of comparative genomic hybridization analysis in effusion -: and fine needle aspiration cytology [J].
Nagel, H ;
Schulten, HJ ;
Gunawan, B ;
Brinck, U ;
Füzesi, L .
MODERN PATHOLOGY, 2002, 15 (08) :818-825
[97]   Amplicon profiles in ovarian serous carcinomas [J].
Nakayama, Kentaro ;
Nakayama, Naomi ;
Jinawath, Natini ;
Salani, Ritu ;
Kurman, Robert J. ;
Shih, Ie-Ming ;
Wang, Tian-Li .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (12) :2613-2617
[98]   Gene Amplification CCNE1 Is Related to Poor Survival and Potential Therapeutic Target in Ovarian Cancer [J].
Nakayama, Naomi ;
Nakayama, Kentaro ;
Shamima, Yeasmin ;
Ishikawa, Masako ;
Katagiri, Atsuko ;
Iida, Kouji ;
Miyazaki, Khoji .
CANCER, 2010, 116 (11) :2621-2634
[99]  
Neragi-Miandoab Siyamek, 2008, Int J Surg, V6, P293, DOI 10.1016/j.ijsu.2008.04.004
[100]   Evidence-Based Medicine in the Treatment of Peritoneal Carcinomatosis: Past, Present, and Future [J].
Nissan, Aviram ;
Stojadinovic, Alexander ;
Garofalo, Alfredo ;
Esquivel, Jesus ;
Piso, Pompiliu .
JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (04) :335-344
567891011121314